More Articles
Developing a Hospital-Based Pharmacy Technician Training Program
Mariel C. Pereda, PharmD, BCPS
Developing a pharmacy technician training program is one way for health systems to increase the availability of highly qualified pharmacy technicians.
Finding Undiagnosed Atrial Fibrillation: Why, What, Who and How
James S. Kalus, PharmD, FASHP
Pharmacists can identify undiagnosed atrial fibrillation and prevent stroke. A plan for screening for atrial fibrillation.
Standardize 4 Safety: How Did It Start and Where Is It Going?
Deborah Pasko, PharmD, BSPharm, MHA
I became interested in standardizing oral liquid and intravenous medication concentrations after seeing and taking care of patients that had experienced adverse events related to medication errors involving the wrong concentration of the medication. I experienced this during my tenure as a Pediatric Intensive Care Pharmacy Specialist from 2003-2009. In addition, in 2005 we purchased new syringe pumps (aka “smart infusion devices”) that could be programmed with the concentration for the practitioner so they could choose from a menu instead of programming themselves. It was starting the era of smart bedside technology and pharmacies needed to catch up to the technology.
A Plea for Standardization
Natasha Nicol, PharmD, FASHP
In the complex processes that make up the medication use system, every step offers an opportunity for error. Effective error reduction is possible if we look at each step and devise ways to reduce the human element, through strategies such as forcing functions (e.g., profiled automation), barriers (e.g., bar coding), and standardization.
What if we are the key? Pharmacist Roles for Oncology Palliative Care
Tonya Smith, PharmD, BCPS
Considering pharmacist roles for integration of palliative care services for oncology patients
Treatment of C. difficile infection in children and adolescents
Travis J. Carlson, PharmD, BCIDP
Evidence regarding the treatment of C. difficile infection in children and adolescents has recently emerged and the results may surprise you!
Prioritizing fulminant C. difficile infection research
Travis J. Carlson, PharmD, BCIDP
Fulminant C. difficile infection is a deadly disease, yet no medication intervention has demonstrated the ability to reduce the risk of mortality.
The Pharmacist as Immunotherapy Educator: Focus on the Human Factor
Jordan McPherson, PharmD, MS, BCOP
Practical pharmacist education with a focus on early intervention, simplicity, and mutual trust can optimize immune-related adverse event management.
Pediatric Eosinophilic Esophagitis: Potentially Big Concerns for Little Patients
Erin Hamai Tom, Pharm.D., APh, MBA, BCACP
Pediatric eosinophilic esophagitis is a rare disease, challenged further by its nonspecific symptomatic presentation and lack of treatment options.
Mitigating Drug Diversion in Ambulatory Procedural Areas
Ryan Haumschild, PharmD, MS, MBA
In order to prevent drug diversion in ambulatory settings pharmacy leaders must adapt their oversight to the changing practices of healthcare delivery.